File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Somatostatin therapy in L-asparaginase-induced pancreatitis

TitleSomatostatin therapy in L-asparaginase-induced pancreatitis
Authors
Cheung, YFLee, CWChan, CFChan, KLLau, YLYeung, CY
Keywordsasparaginase
pancreatitis
somatostatin
Issue Date1994
Citation
Medical And Pediatric Oncology, 1994, v. 22 n. 6, p. 421-424 How to Cite?
DOI: http://dx.doi.org/10.1002/mpo.2950220614
AbstractL-Asparaginase-induced pancreatitis is an uncommon but potentially lethal complication. An 8-year-old girl with acute lymphoblastic leukaemia developed acute pancreatitis following treatment with asparaginase. Clinical and laboratory improvements were evident after treatment with somatostatin, with no complications of pancreatitis. Induction therapy for the leukaemia was able to be continued and complete remission was documented during the course of pancreatitis and somatostatin treatment, suggesting a beneficial role of somatostatin in the management of asparaginase-induced pancreatitis.
Persistent Identifierhttp://hdl.handle.net/10722/170275
ISSN
0098-1532
ISI Accession Number ID
WOS:A1994NG22700013

 

DC FieldValueLanguage
dc.contributor.authorCheung, YFen_US
dc.contributor.authorLee, CWen_US
dc.contributor.authorChan, CFen_US
dc.contributor.authorChan, KLen_US
dc.contributor.authorLau, YLen_US
dc.contributor.authorYeung, CYen_US
dc.date.accessioned2012-10-30T06:07:09Z-
dc.date.available2012-10-30T06:07:09Z-
dc.date.issued1994en_US
dc.identifier.citationMedical And Pediatric Oncology, 1994, v. 22 n. 6, p. 421-424en_US
dc.identifier.issn0098-1532en_US
dc.identifier.urihttp://hdl.handle.net/10722/170275-
dc.description.abstractL-Asparaginase-induced pancreatitis is an uncommon but potentially lethal complication. An 8-year-old girl with acute lymphoblastic leukaemia developed acute pancreatitis following treatment with asparaginase. Clinical and laboratory improvements were evident after treatment with somatostatin, with no complications of pancreatitis. Induction therapy for the leukaemia was able to be continued and complete remission was documented during the course of pancreatitis and somatostatin treatment, suggesting a beneficial role of somatostatin in the management of asparaginase-induced pancreatitis.en_US
dc.languageengen_US
dc.relation.ispartofMedical and Pediatric Oncologyen_US
dc.rightsMedical and Pediatric Oncology. Copyright © John Wiley & Sons, Inc.-
dc.subjectasparaginase-
dc.subjectpancreatitis-
dc.subjectsomatostatin-
dc.subject.meshAcute Diseaseen_US
dc.subject.meshAsparaginase - Adverse Effectsen_US
dc.subject.meshChilden_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshPancreatitis - Chemically Induced - Drug Therapyen_US
dc.subject.meshPrecursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapyen_US
dc.subject.meshSomatostatin - Therapeutic Useen_US
dc.titleSomatostatin therapy in L-asparaginase-induced pancreatitisen_US
dc.typeArticleen_US
dc.identifier.emailCheung, YF:xfcheung@hku.hken_US
dc.identifier.emailLau, YL:lauylung@hkucc.hku.hken_US
dc.identifier.authorityCheung, YF=rp00382en_US
dc.identifier.authorityLau, YL=rp00361en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1002/mpo.2950220614-
dc.identifier.pmid7908715-
dc.identifier.scopuseid_2-s2.0-0028330881en_US
dc.identifier.hkuros3998-
dc.identifier.volume22en_US
dc.identifier.issue6en_US
dc.identifier.spage421en_US
dc.identifier.epage424en_US
dc.identifier.isiWOS:A1994NG22700013-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridCheung, YF=7202111067en_US
dc.identifier.scopusauthoridLee, CW=16157380600en_US
dc.identifier.scopusauthoridChan, CF=36984590800en_US
dc.identifier.scopusauthoridChan, KL=25622512400en_US
dc.identifier.scopusauthoridLau, YL=7201403380en_US
dc.identifier.scopusauthoridYeung, CY=25950985200en_US
dc.identifier.issnl0098-1532-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats